DA5-CH and Semaglutide Protect against Neurodegeneration and Reduce α-Synuclein Levels in the 6-OHDA Parkinson’s Disease Rat Model

Figure 1

Schematic diagram of the study. The timeline and sequence of treatments conducted are shown.